Knowledge, attitudes and practices of pharmacists about pharmacovigilance, Libya



Atia A, Botto A, Alarbi S.


East Mediterr Health J. 2021 Jul 29;27(7):693-697. doi: 10.26719/2021.27.7.693.


BACKGROUND: The concept of pharmacovigilance is not well known in Libya and its practice is still in the early stages. AIMS: This study aimed to determine the knowledge, attitudes and practices of pharmacists in Tripoli, Libya about pharmacovigilance and the reporting of adverse drug reactions. METHODS: A cross-sectional study was conducted from October 2019 to February 2020 of working pharmacists randomly selected from pharmacies in Tripoli. Participants were eligible for inclusion if they had a degree or diploma in pharmacy from a recognized university or institute. Data were collected using a validated self-administered questionnaire. RESULTS: Of 500 pharmacists selected, 408 completed the questionnaire. The pharmacists’ knowledge of pharmacovigilance and reporting of adverse drug reactions was poor overall: only 28.9% correctly defined pharmacovigilance and 14.7% knew about the existence of a centre for pharmacovigilance in Libya. The attitudes of the pharmacists to pharmacovigilance was positive: 77.2% believed that pharmacovigilance needed to be included in the pharmacy curriculum and 73.0% said that they would practice pharmacovigilance if trained. Pharmacists depended mostly on drug information leaflets to update their knowledge on adverse drug reactions. CONCLUSION: Given the pharmacists’ low level of knowledge about pharmacovigilance but their readiness to become involved if trained, training programmes should be introduced for practising pharmacists to improve their knowledge and encourage their active participation in pharmacovigilance. Regulators need to reinforce the importance of reporting adverse drug reactions and implement pharmacovigilance policies in the Libyan health care system. CI – Copyright © World Health Organization (WHO) 2021. Open Access. Some rights reserved. This work is available under the CC BY-NC-SA 3.0 IGO license (

Keywords: .

Link/DOI: 10.26719/2021.27.7.693